Anti PD-L1 (Atezolizumab) as an Immune Primer and Concurrently With Extended Field Chemoradiotherapy for Node Positive Locally Advanced Cervical Cancer
Latest Information Update: 18 Oct 2024
At a glance
- Drugs Atezolizumab (Primary) ; Cisplatin (Primary)
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 15 Oct 2024 Planned End Date changed from 21 Sep 2024 to 18 Sep 2025.
- 23 Sep 2023 Planned End Date changed from 23 May 2024 to 21 Sep 2024.
- 26 Jun 2023 Planned End Date changed from 23 May 2023 to 23 May 2024.